Blog

April 25, 2024

Navigating Patient-First Engagement in an Escalating Privacy-Conscious Era

OptimizeRx

The healthcare industry thrives on innovation, and that includes the way it reaches patients. Traditionally, pharmaceutical marketers targeted patients via their treating HCPs and used expensive mass media to promote brands to consumers;...

September 21, 2022

Hub and Specialty Pharmacy Models West Takeaways: Overcoming Prior Authorization Hurdles with Technology

Karina Castagna

Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care In almost every therapy area, utilization management, prior authorizations, and step therapy requirements increased between 2014 and 2020. For example, in...

August 30, 2022

Increased Osteoarthritis Brand Awareness and Prescribing Through Copay Promotion

OptimizeRx

There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of almost $140 Billion annually.

August 9, 2022

Addressing Medication Affordability in Vulnerable Patients During COVID-19

OptimizeRx

Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the estimated 40% of Americans living with a medical-related ailment that...

July 28, 2022

What’s Your Market Access Digital Maturity?

OptimizeRx

When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and easily. Formulary awareness, patient enrollment, and onboarding,...

July 26, 2022

Improving Access to Mental Healthcare with OptimizeRx Financial Messaging

OptimizeRx

The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a steady increase every year since 2011.

June 2, 2022

Making the Case for a Digital Revolution in Market Access

OptimizeRx

As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many different hurdles to adapting their market access strategies for a...

April 21, 2022

The RWD Win/Win: A Strategy that Delivers for Pharma, Patients, HCPs and More

Mike Rousselle

Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this methodology across the full patient journey and product lifecycle...

March 31, 2022

Implementing a Practical Approach to AI and Real World Data that Improves Care Journeys

Mike Rousselle

Offering a Practical Approach to AI and Real World Data Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand teams are still working to find and implement applicable use cases...

November 19, 2021

HCP Targeting: Be there when your ideal patient and provider meet

OptimizeRx

Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how brand teams can harness the power of today’s artificial...

November 12, 2021

Overcoming Challenges Related to Multiple Sclerosis Treatment: The Complete Picture

OptimizeRx

Key Themes and Takeways from Our Multiple Sclerosis Series In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas that can impact their health outcomes: Delayed diagnosis or...

November 5, 2021

Overcoming Challenges Related to Multiple Sclerosis Treatment: Patient Adherence

OptimizeRx

Part Three of Our Multiple Sclerosis Series In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness in order to reduce occurrences of delayed or incorrect diagnosis...